Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android


Therapeutic Approach

Pigmented purpuric dermatoses (PPD) encompass subtypes of generally benign, chronic purpuric cutaneous eruptions, most commonly over the lower extremities, characterized by erythematous to violaceous macules, patches, and petechiae. PPD classifications include progressive pigmentary purpura or Schamberg’s disease (PPP), purpura annularis telangiectodes of Majocchi (PATM), lichen aureus (LA), pigmented purpuric lichenoid dermatitis of Gougerot and Blum (PPLD), eczematoid-like purpura of Doucas and Kapetanakis (EP), with other rare variants including disseminated pruriginous angiodermatitis, unilateral linear capillaritis (ULC), and granulomatous pigmented purpura (GPP). Treatment of PPD primarily focuses on managing the underlying aggravating factors including compression for venous insufficiency, discontinuation of suspected PPD-inducing drugs, as well as topical and systemic therapies outlined below. PPD are usually persistent and resistant to therapy. See Table 130-1.

Table 130-1Pigmented Purpuric Dermatoses Treatment Table

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.